ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 191 filers reported holding ARRAY BIOPHARMA INC in Q3 2017. The put-call ratio across all filers is 0.75 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2018 | $685,000 | +84.1% | 48,058 | +8.3% | 0.12% | +68.6% |
Q2 2017 | $372,000 | +22.8% | 44,385 | +31.2% | 0.07% | -1.4% |
Q1 2017 | $303,000 | +203.0% | 33,839 | +43.3% | 0.07% | +136.7% |
Q4 2015 | $100,000 | +37.0% | 23,609 | +47.8% | 0.03% | +20.0% |
Q3 2015 | $73,000 | – | 15,976 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
BVF INC/IL | 9,719,589 | $60,456,000 | 10.40% |
KOPP INVESTMENT ADVISORS LLC | 2,808,537 | $17,470,000 | 6.42% |
Redmile Group, LLC | 3,669,593 | $22,825,000 | 3.44% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 10,585,406 | $65,841,000 | 3.06% |
QVT Financial LP | 2,878,600 | $17,905,000 | 1.22% |
APEX CAPITAL, LLC | 2,500,000 | $15,550,000 | 1.12% |
FBR & Co. | 113,500 | $706,000 | 1.07% |
Artal Group S.A. | 3,000,000 | $18,660,000 | 0.61% |
Perimeter Capital Partners, LLC | 486,478 | $3,026,000 | 0.56% |
Orbimed Advisors | 4,831,600 | $30,053,000 | 0.54% |